Related Experiment Video
Updated: Jun 13, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Anticoagulation for renal replacement therapy: different methods to improve safety
Abstract:
The different methods for anticoagulation of the extracorporeal circuit for renal replacement therapy (RRT) vary in safety profile, bleeding being the most important side effect. Avoiding severe bleeding is a key aim of RRT prescription. The present paper is a clinical review comparing regional anticoagulation with citrate to heparin for continuous RRT, and different anticoagulant strategies for prolonged intermittent therapies. Regional anticoagulation with citrate or the use of prostacyclins provide high safety because they do not increase the patient's risk of bleeding. The use of citrate may additionally increase biocompatibility. However, both confer other risks when used without understanding and therefore require carefully designed protocols for bedside use with guidelines for early detection and management of complications. If so, the use of citrate may improve patient and kidney survival. Further studies are needed to confirm and explain this benefit.
More Related Videos
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
